

IRX develops immune therapies designed to activate a patient’s immune system to defeat cancer and related diseases.
| Headquarter | 140 West 57th Street, Suite 3D New York City, NY United States of America |
|---|---|
| Website | irxtherapeutics.com |
| Tel | (212) 582-1199 |
| Company Status | Private |

Mark Leuchtenberger CEO / President
Mark Leuchtenberger serves as the CEO / President of IRX Therapeutics.

Ron Guido Vice President Regulatory Affairs
Ron Guido serves as the Vice President Regulatory Affairs of IRX Therapeutics.

No Recent Jobs found for IRX Therapeutics on Comparably
Mark that you are interested and we will alert you when there are new positions available listed on Comparably
In 2019, IRX Therapeutics applied for 1 H1B visas. Of the work permits applied for, 100% were approved.
H1B Applications Outcome
This data was calculated using publicly sourced data from OFLC Performance Data

What is IRX Therapeutics address?
IRX Therapeutics location is at 140 West 57th Street, Suite 3D
Who is IRX Therapeutics leadership?
Ron Guido are part of IRX Therapeutics leadership, Mark Leuchtenberger is the CEO